{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:05:44Z","timestamp":1761102344577},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773188","81760557"],"award-info":[{"award-number":["81773188","81760557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The expression of I\u03baB kinase \u03b2 (IKK\u03b2) promotes the growth of breast cancer cells. Meanwhile, IKK\u03b2 mediates the phosphorylation and subsequent degradation of arrest-defective protein 1 (ARD1). However, the relationship between IKK\u03b2 and ARD1 in the occurrence of breast cancer has not been reported. In this study, we found that IKK\u03b2 not only acts directly on mammalian target of rapamycin (mTOR) activity but also indirectly acts on mTOR activity through posttranscriptional modification of ARD1, thereby effectively promoting the growth of breast cancer cells. ARD1 prevents mTOR activity and breast cancer cell growth by stabilizing tuberous sclerosis complex 2 (TSC2) to induce autophagy. Moreover, acetylation of heat shock protein 70 (Hsp70) also contributes to ARD1-mediated autophagy. Therefore, upstream IKK\u03b2 can further promote the occurrence of breast cancer by mediating the function of ARD1.<\/jats:p>","DOI":"10.1038\/s41419-018-0921-2","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T21:23:22Z","timestamp":1535491402000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["ARD1 contributes to IKK\u03b2-mediated breast cancer tumorigenesis"],"prefix":"10.1038","volume":"9","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlai","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"921_CR1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621\u2013663 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"921_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0092-8674(04)00302-2","volume":"117","author":"MC Hu","year":"2004","unstructured":"Hu, M. C. et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225\u2013237 (2004).","journal-title":"Cell"},{"key":"921_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2, 301\u2013310 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"921_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., Lenardo, M. J. & Baltimore, D. 30 Years of NF-kappaB: a blossoming of relevance to human pathobiology. Cell 168, 37\u201357 (2017).","journal-title":"Cell"},{"key":"921_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","volume":"130","author":"DF Lee","year":"2007","unstructured":"Lee, D. F. et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440\u2013455 (2007).","journal-title":"Cell"},{"key":"921_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbrc.2009.08.127","volume":"389","author":"HP Kuo","year":"2009","unstructured":"Kuo, H. P. et al. Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation. Biochem. Biophys. Res. Commun. 389, 156\u2013161 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"921_CR7","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/j.1460-2075.1989.tb03615.x","volume":"8","author":"JR Mullen","year":"1989","unstructured":"Mullen, J. R. et al. Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast. EMBO J. 8, 2067\u20132075 (1989).","journal-title":"EMBO J."},{"key":"921_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/onc.2012.82","volume":"32","author":"TV Kalvik","year":"2013","unstructured":"Kalvik, T. V. & Arnesen, T. Protein N-terminal acetyltransferases in cancer. Oncogene 32, 269\u2013276 (2013).","journal-title":"Oncogene"},{"key":"921_CR9","doi-asserted-by":"publisher","first-page":"10677","DOI":"10.1158\/0008-5472.CAN-06-3171","volume":"66","author":"JH Lim","year":"2006","unstructured":"Lim, J. H., Park, J. W. & Chun, Y. S. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res. 66, 10677\u201310682 (2006).","journal-title":"Cancer Res."},{"key":"921_CR10","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1172\/JCI42275","volume":"120","author":"CF Lee","year":"2010","unstructured":"Lee, C. F. et al. hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J. Clin. Invest. 120, 2920\u20132930 (2010).","journal-title":"J. Clin. Invest."},{"key":"921_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3109\/07357900902769723","volume":"27","author":"M Yu","year":"2009","unstructured":"Yu, M. et al. Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer. Cancer Invest. 27, 978\u2013983 (2009).","journal-title":"Cancer Invest."},{"key":"921_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.canlet.2008.01.028","volume":"264","author":"T Ren","year":"2008","unstructured":"Ren, T. et al. Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer. Cancer Lett. 264, 83\u201392 (2008).","journal-title":"Cancer Lett."},{"key":"921_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1349-7006.2002.tb01301.x","volume":"93","author":"Y Midorikawa","year":"2002","unstructured":"Midorikawa, Y. et al. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn J. Cancer Res. 93, 636\u2013643 (2002).","journal-title":"Jpn J. Cancer Res."},{"key":"921_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2353\/ajpath.2010.091178","volume":"177","author":"B Jiang","year":"2010","unstructured":"Jiang, B. et al. Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients. Am. J. Pathol. 177, 1095\u20131103 (2010).","journal-title":"Am. J. Pathol."},{"key":"921_CR15","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/carcin\/bgs144","volume":"33","author":"H Xu","year":"2012","unstructured":"Xu, H. et al. N-alpha-acetyltransferase 10 protein inhibits apoptosis through RelA\/p65-regulated MCL1 expression. Carcinogenesis 33, 1193\u20131202 (2012).","journal-title":"Carcinogenesis"},{"key":"921_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.200708090","volume":"179","author":"CH Yi","year":"2007","unstructured":"Yi, C. H. et al. A genome-wide RNAi screen reveals multiple regulators of caspase activation. J. Cell Biol. 179, 619\u2013626 (2007).","journal-title":"J. Cell Biol."},{"key":"921_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ccr.2010.11.010","volume":"19","author":"KT Hua","year":"2011","unstructured":"Hua, K. T. et al. N-alpha-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42\/Rac1 activity. Cancer Cell 19, 218\u2013231 (2011).","journal-title":"Cancer Cell"},{"key":"921_CR18","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/carcin\/bgu132","volume":"35","author":"Y Zeng","year":"2014","unstructured":"Zeng, Y. et al. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis. Carcinogenesis 35, 2244\u20132253 (2014).","journal-title":"Carcinogenesis"},{"key":"921_CR19","doi-asserted-by":"publisher","first-page":"ra9","DOI":"10.1126\/scisignal.2000590","volume":"3","author":"HP Kuo","year":"2010","unstructured":"Kuo, H. P. et al. ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci. Signal. 3, ra9 (2010).","journal-title":"Sci. Signal."},{"key":"921_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/emboj.2009.364","volume":"29","author":"A Criollo.","year":"2010","unstructured":"Criollo., A. et al. The IKK complex contributes to the induction of autophagy. EMBO J. 29, 619\u2013631 (2010).","journal-title":"EMBO J."},{"key":"921_CR21","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829\u20131834 (2003).","journal-title":"Genes Dev."},{"key":"921_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/cdd.2009.46","volume":"16","author":"E Laane","year":"2009","unstructured":"Laane, E. et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ. 16, 1018\u20131029 (2009).","journal-title":"Cell Death Differ."},{"key":"921_CR23","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1073\/pnas.1217692110","volume":"110","author":"Y Yang","year":"2013","unstructured":"Yang, Y. et al. Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagy. Proc. Natl Acad. Sci. USA 110, 6841\u20136846 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"921_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12882","volume":"7","author":"JH Seo","year":"2016","unstructured":"Seo, J. H. et al. ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. Nat. Commun. 7, 12882 (2016).","journal-title":"Nat. Commun."},{"key":"921_CR25","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1158\/0008-5472.CAN-14-2111","volume":"75","author":"C Chen","year":"2015","unstructured":"Chen, C. et al. IKKbeta enforces a LIN28B\/TCF7L2 positive feedback loop that promotes cancer cell stemness and metastasis. Cancer Res. 75, 1725\u20131735 (2015).","journal-title":"Cancer Res."},{"key":"921_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1158\/1541-7786.MCR-17-0157","volume":"15","author":"A Page","year":"2017","unstructured":"Page, A. et al. IKKbeta-mediated resistance to skin cancer development is Ink4a\/Arf-dependent. Mol. Cancer Res. 15, 1255\u20131264 (2017).","journal-title":"Mol. Cancer Res."},{"key":"921_CR27","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1084\/jem.20150576","volume":"212","author":"CK Pallangyo","year":"2015","unstructured":"Pallangyo, C. K., Ziegler, P. K. & Greten, F. R. IKKbeta acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis. J. Exp. Med. 212, 2253\u20132266 (2015).","journal-title":"J. Exp. Med."},{"key":"921_CR28","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1084\/jem.20150542","volume":"212","author":"V Koliaraki","year":"2015","unstructured":"Koliaraki, V., Pasparakis, M. & Kollias, G. IKKbeta in intestinal mesenchymal cells promotes initiation of colitis-associated cancer. J. Exp. Med. 212, 2235\u20132251 (2015).","journal-title":"J. Exp. Med."},{"key":"921_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ccell.2015.02.004","volume":"27","author":"B Liu","year":"2015","unstructured":"Liu, B. et al. A cytoplasmic NF-kappaB interacting long noncoding RNA blocks IkappaB phosphorylation and suppresses breast cancer metastasis. Cancer Cell 27, 370\u2013381 (2015).","journal-title":"Cancer Cell"},{"key":"921_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01829-1","volume":"8","author":"F Fusella","year":"2017","unstructured":"Fusella, F. et al. The IKK\/NF-kappaB signaling pathway requires Morgana to drive breast cancer metastasis. Nat. Commun. 8, 1636 (2017).","journal-title":"Nat. Commun."},{"key":"921_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3892\/ijo.2017.4039","volume":"51","author":"YH Park","year":"2017","unstructured":"Park, Y. H., Seo, J. H., Park, J. H., Lee, H. S. & Kim, K. W. Hsp70 acetylation prevents caspase-dependent\/independent apoptosis and autophagic cell death in cancer cells. Int. J. Oncol. 51, 573\u2013578 (2017).","journal-title":"Int. J. Oncol."},{"key":"921_CR32","doi-asserted-by":"crossref","first-page":"51970","DOI":"10.18632\/oncotarget.17583","volume":"8","author":"Y Tang","year":"2017","unstructured":"Tang, Y. et al. Chaperone-mediated autophagy substrate proteins in cancer. Oncotarget 8, 51970\u201351985 (2017).","journal-title":"Oncotarget"},{"key":"921_CR33","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3892\/ijo.2015.3213","volume":"47","author":"T Mawatari","year":"2015","unstructured":"Mawatari, T. et al. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation. Int. J. Oncol. 47, 2073\u20132081 (2015).","journal-title":"Int. J. Oncol."},{"key":"921_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.canlet.2014.08.031","volume":"354","author":"MY Wu","year":"2014","unstructured":"Wu, M. Y., Fu, J., Xiao, X., Wu, J. & Wu, R. C. MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer. Cancer Lett. 354, 311\u2013319 (2014).","journal-title":"Cancer Lett."},{"key":"921_CR35","doi-asserted-by":"crossref","first-page":"80770","DOI":"10.18632\/oncotarget.20415","volume":"8","author":"H Zhou","year":"2017","unstructured":"Zhou, H. et al. PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines. Oncotarget 8, 80770\u201380789 (2017).","journal-title":"Oncotarget"},{"key":"921_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.559","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion. Cell Death Dis. 8, e3151 (2017).","journal-title":"Cell Death Dis."},{"key":"921_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.276","volume":"6","author":"W Guo","year":"2015","unstructured":"Guo, W. et al. Caspase-3 feedback loop enhances Bid-induced AIF\/endoG and Bak activation in Bax and p53-independent manner. Cell Death Dis. 6, e1919 (2015).","journal-title":"Cell Death Dis."},{"key":"921_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1074\/jbc.M111.271205","volume":"287","author":"W Hu","year":"2012","unstructured":"Hu, W. et al. Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. J. Biol. Chem. 287, 68\u201380 (2012).","journal-title":"J. Biol. Chem."},{"key":"921_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.onc.1200861","volume":"14","author":"JY Chang","year":"1997","unstructured":"Chang, J. Y. et al. The tumor suppression activity of E1A in HER-2\/neu-overexpressing breast cancer. Oncogene 14, 561\u2013568 (1997).","journal-title":"Oncogene"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0921-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0921-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0921-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:05:42Z","timestamp":1671537942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0921-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["921"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0921-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"3 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"860"}}